Clinical Trial Update: Vitamin D Supplementations as Adjunct to Anti-Tuberculosis Drugs in Mongolia [NA]

View source ↗

Summary

A completed clinical trial in Mongolia studied Vitamin D supplementation as an adjunct to standard anti-tuberculosis therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Harvard School of Public Health (HSPH) | Conditions: Vitamin D Supplements, Tuberculosis | NA | Status: COMPLETED